Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Microneedle-Assisted Photodynamic Therapy for Actinic Keratosis (MNPDT-II)
NCT02594644Completed
- Sponsor
- University of California, Davis
- Start
- Nov 2014
- Primary completion
- Jun 2016
- Countries
- 1
01
Overview
Randomised, single-blind trial of 5-aminolevulinic acid in actinic keratosis (AK), sponsored by University of California, Davis. Primary endpoint: Percentage of Complete Clearance of the Actinic Keratoses at 2 months. Started Nov 2014; status: completed.
02
Drugs
5-aminolevulinic acid
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT02594644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02594644.